
Mobius Biotechnology is a discovery-stage biotech company focused on developing novel anticancer drugs. They utilize a unique, clinically validated platform that integrates frontier AI capabilities, deep disease insights, and a wet lab platform to interrogate disease mechanisms directly in live human tissue samples. This approach aims to overcome the high failure rate of drugs tested in animal models by focusing on human biology, ultimately delivering medicines designed for clinical success. The company is comprised of an international team of drug hunters, engineers, and entrepreneurs dedicated to bringing transformative treatments to patients with high unmet medical needs.

Mobius Biotechnology is a discovery-stage biotech company focused on developing novel anticancer drugs. They utilize a unique, clinically validated platform that integrates frontier AI capabilities, deep disease insights, and a wet lab platform to interrogate disease mechanisms directly in live human tissue samples. This approach aims to overcome the high failure rate of drugs tested in animal models by focusing on human biology, ultimately delivering medicines designed for clinical success. The company is comprised of an international team of drug hunters, engineers, and entrepreneurs dedicated to bringing transformative treatments to patients with high unmet medical needs.